Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000543203 | SCV000644400 | likely benign | Tuberous sclerosis 2 | 2024-12-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000612484 | SCV000728055 | likely benign | not specified | 2018-03-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV001018244 | SCV001179455 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000543203 | SCV002039281 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003392390 | SCV004133841 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |
All of Us Research Program, |
RCV003999284 | SCV004818724 | likely benign | Tuberous sclerosis syndrome | 2024-05-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV003392390 | SCV005216990 | likely benign | not provided | criteria provided, single submitter | not provided |